CASM Average Annual Return 10 Years
Growth of $10,000.00
Without Dividends Reinvested Into CASM


Also see:
CASM stock yearly return 2011
CASM stock yearly return 2012
CASM stock yearly return 2013
CASM stock yearly return 2014
CASM stock yearly return 2015
CASM stock yearly return 2016
CASM stock yearly return 2017
CASM stock yearly return 2018
CASM stock yearly return 2019
CASM stock yearly return 2020
CASM YTD return
Compare CASM average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Start date: 09/14/2011
End date: 04/18/2019
Start price/share: $2.63
End price/share: $2.45
Dividends collected/share: $0.00
Total return: -6.84%
Average Annual Total Return: -0.93%
Starting investment: $10,000.00
Ending investment: $9,314.76
Years: 7.60


CASM average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
CAS Medical Systems is a medical technology company that develops, manufactures, and distributes non-invasive patient monitoring products for patient care. Co. has two categories of sales within one reportable business unit: Tissue Oximetry Monitoring, which includes sales of Co.'s FORE-SIGHT tissue oximeter monitors, sensors and accessories; and Service and Other, which includes sales of service parts and repairs and other miscellaneous sales, as well as various repair services to its customers for legacy and FORE-SIGHT monitors installed in the field. Co. markets its products worldwide through its sales force, distributors, and manufacturers' representatives. The CASM average annual return 10 years is shown above.

The Average Annual Return on the CASM average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether CASM average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the CASM average annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes
Get Free SEC filing alerts for CASM:
CASM SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
CASM (CASM) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

CATB Average Annual Return
CATS Average Annual Return
CBAY Average Annual Return
CBIO Average Annual Return
CBLI Average Annual Return
CBM Average Annual Return
CBMG Average Annual Return
CBPO Average Annual Return
CCRN Average Annual Return
CCXI Average Annual Return
More Healthcare companies »

 

CASM Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.